Duane Morris Home
Search Site | Languages | Site Map | Alumni | Careers | Contact Us | Watch Duane Morris Video Listen to Duane Morris Podcasts, Webcasts and Audio Connect with Duane Morris LLP on LinkedIn Follow Duane Morris LLP on Facebook Follow Duane Morris LLP on Twitter Subscribe to RSS feed
  • About Duane Morris  ∨
    • Annual Report
    • Firm Rankings and Statistics
    • Past and Present
    • Firm Accolades and Honors
    • Attorney Accolades and Honors
    • Diversity and Inclusion
    • Women's Initiative
    • Pro Bono
  • Practices and Industries  ∨
    • Expanded Service Area Listing
  • People
  • Offices
  • Annual Report
  • News, Pubs and Multimedia  ∨
    • Alerts and Updates
    • Bylined Articles
    • In the News
    • Press Releases
    • For the Press
    • Video
    • Podcasts
    • Blogs
  • Events
  • Affiliates

Publications
Events
For the Press

Home > News > Press Releases and Announcements

SHARE: Email this page Print This

Press Release

Corporate Partner Richard Silfen Joins Duane Morris in Philadelphia

PHILADELPHIA, January 23, 2007 - Duane Morris LLP is pleased to welcome Richard A. Silfen as a partner in its Philadelphia office. Richard joins the firm's Corporate Practice Group from corporate roles at Cangen Biotechnologies, Inc., a biotechnology company, and GMH Communities Trust, a real estate investment trust.

An accomplished corporate lawyer, Richard will focus his practice in securities offerings and merger and acquisition transactions, as well as venture capital and private equity investments. He has represented clients in the biotechnology, pharmaceutical, medical devices and high-technology industries, assisting them with technology development and implementation plans, strategic partnerships, collaborations and joint ventures. Richard also has extensive experience counseling real estate investment trusts in business and financial matters.

Richard brings to Duane Morris a rich background in both the life sciences and REIT industries and in law. At GMH, he served as chairman of the Special Committee of the Board of Trustees in charge of identifying and pursuing strategic and financial alternatives for the future of the company. Richard also served as president and chief financial officer at Cangen Biotechnologies, Inc., a Bethesda, Maryland-based biotechnology company with offices in Tokyo and Seoul. Before that, he practiced privately at several law firms, most recently Morgan, Lewis & Bockius LLP in Philadelphia, where he was a partner. Richard also practiced as a staff attorney at the U.S. Securities and Exchange Commission, Division of Corporation Finance. He served in the Office of Mergers and Acquisitions and Office of Chief Counsel.

A 1987 graduate of the University of Alabama School of Law, Richard earned his B.A. from Baylor University, where he majored in physics.

About Duane Morris

Duane Morris LLP, among the 100 largest law firms in the world, is a full-service firm of more than 600 lawyers. In addition to legal services, Duane Morris has independent affiliates employing approximately 100 professionals engaged in other disciplines. With offices in major markets, and as part of an international network of independent law firms, Duane Morris represents clients across the United States and around the world.

 

Duane Morris LLP & Affiliates. © 1998-2013 Duane Morris LLP. Duane Morris is registered service mark of Duane Morris LLP. Disclaimer | Privacy | Attorney Advertising
Other Languages: Chinese • Deutsch • Español • Français • Português